We are live on ! Find out more
STXS icon

Stereotaxis

0.8626 USD
-0.0474
5.21%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
0.8980
+0.0354
4.1%
1 day
-5.21%
5 days
-16.25%
1 month
-29.87%
3 months
-35.14%
6 months
-53.87%
Year to date
-62.82%
1 year
-70.46%
5 years
-85.81%
10 years
-74.17%
 

About: Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Employees: 131

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 12.5%
Neutral 75%
Negative 12.5%
Neutral
GlobeNewsWire
8 days ago
Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
ST. LOUIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Pauls Stradiņš Clinical University Hospital in Riga, Latvia, has established the first robotic center for the treatment of cardiac arrhythmias in Latvia and has successfully treated initial patients with the Genesis Robotic Magnetic Navigation System.
Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia
Neutral
GlobeNewsWire
10 days ago
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
ST. LOUIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 third quarter on Tuesday, November 10, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company's results and corporate developments.
Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026
Neutral
GlobeNewsWire
1 month ago
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society's HRX 2026
New digital technologies, including Synchrony and SynX, will be featured at HRX Stereotaxis CEO to join main-stage panel on Autonomous EP Systems ST. LOUIS, Sept.
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society's HRX 2026
Neutral
GlobeNewsWire
1 month ago
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
ST. LOUIS, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that the Electrophysiology team at the University of Szeged in Hungary has successfully treated over 70 patients using the Genesis Robotic Magnetic Navigation system, just over a month after launching its robotic cardiology program.
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
Neutral
Seeking Alpha
2 months ago
Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript
Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript
Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript
Positive
MarketBeat
2 months ago
Stereotaxis Q2 Earnings Call Highlights
Stereotaxis NYSEAMERICAN: STXS reported second-quarter 2026 revenue of $7.7 million, as growth in sales of its robotic catheter portfolio helped lift recurring revenue to a multiyear high despite lower system revenue and continued supply constraints.
Stereotaxis Q2 Earnings Call Highlights
Negative
Zacks Investment Research
2 months ago
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.05 per share a year ago.
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
Neutral
GlobeNewsWire
2 months ago
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
ST. LOUIS, Mo., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the second quarter ended June 30, 2026.
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
Neutral
GlobeNewsWire
3 months ago
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
ST. LOUIS, July 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 second quarter on Tuesday, August 11, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m.
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
Neutral
GlobeNewsWire
3 months ago
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
First Robotic Magnetic Navigation system installed in Hungary University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using precision of robotics ST. LOUIS, July 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
Price charts implemented using Lightweight Charts™